Pharmaceutical companies are closely monitoring the potential effect of the coronavirus on the supply of medicines and raw materials sourced from Asia, SA’s biggest trade association for drug manufacturers said on Wednesday.

Fears of potential medicine shortages have been heightened by India’s announcement on Tuesday that it plans to curtail exports of some common drugs due to growing concerns over a shortage of key ingredients sourced from China, the epicentre of the coronavirus epidemic.

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now